Test how Your genome affects Your personal health

Negen is a genetic testing and analysing techology company founded by geneticists and physicians.

Our scientifically high quality, cost-effective services enables earliest identification and prevention of multifactorial diseases, which include diabetes, cardiovascular diseases and deep vein thrombosis and make the benefits of genetic information and pharmacogenetics available to the general public.

Health is in Our DNA

More information about Negen gene tests

We have developed a risk calculator for You to see your risk projections and how Your lifestyle values alters the risk for coronary heart disease and type 2 diabetes. The counter combines three different genetic profiles in your lifestyle - low, average and high risk profiles. By ordering the Negen 360 genomic analysis, you will receive Your individual genomic risk factors presented in the calculator and many other features.

Try the Calculator

Consumer gene tests
Biobanks

Negen 360

Negen 360 is our most comprehensive analysis package. The analysis includes a genome wide test panel for coronary artery disease and type 2 diabetes combined with Your lifestyle values. It also includes a test for the most common mutations for deep vein thrombosis.

The test gives you a comprehensive assessment of the risks for the most common non communicable diseases and provides you tools to preserve Your health and maximize your healthy years.

Popular

Negen - Diabetes

In the Negen - Diabetes analysis, we examine the impact that your genome and lifestyles have on your risk of diabetes. The test includes an analysis of Type 2 diabetes as well as the conventional risk factors for Type 2 diabetes (predisposition to overweight, lipids and blood pressure).

Negen - Heart

In the Negen - Heart analysis, we examine the impact that your genome and lifestyles have on your risk of coronary heart disease. The test also includes an analysis of major risk factors: predisposition to overweight or obesity, lipids and blood pressure.

From sample collection to Data utilization

Donors rarely, if ever, receive any genetic information, even when their samples have been genotyped.

Cooperation between Negen and Biobanks enable the return of genetic health data in a cost-effective way, for the donor's benefit. The provision of health-related genetic information to donors in the biobanking industry concretely benefits both the donors and the biobanks.

Kimmo Aro

Managing Director
kimmo.aro@negen.fi
+358 40 149 3210

YOUR GENES, YOUR HABITS, YOUR HEALTH

Together, genes and lifestyle factors form a personal risk for contracting multifactorial diseases, which include diabetes and cardiovascular diseases. Analysing your personal genetic risk allows you to prevent the onset of these diseases as effectively as possible.

"Knowing my genetically increased risk for Coronary Heart Disease motivated me to lower my blood pressure by losing my weight 11 pounds and reducing the usage of salt.

Now my total risk is below the average in my age group”.

45 Year old male

News

Genetic risk assessment delivers measurable value to consumers

Are currently available genomic testing services reliable? And can they deliver real value? Here we attempt to answer both questions comprehensively.

Negen partners with BC Platforms for early risk assessment of common diseases

Negen is excited to announce a cooperation agreement with BC Platforms, a leading provider of genomic data management and analytics. Negen’s advanced Genetic Risk Scoring tools will be integrated with BC Platforms’ state-of-the-art genomic data management platform, leading to advances in data processing and interpretation. Working together, these two leading genomics data companies will provide a premium, integrated solution to healthcare providers and customers around the world.